BAD VILBEL, Germany and REYKJAVIK, Iceland, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Partners STADA and Alvotech today announced that the European Commission issued a marketing authorization for Uzpruvo® ...
Patients with refractory Crohn’s disease who previously received ustekinumab experienced clinical and endoscopic improvements ...
Biocon Biologics has received permission from the Food and Drug Administration for Yesintek (ustekinumab-kfce), which is a biosimilar to Stelara. Yesintek, a monoclonal antibody, is approved for the ...
The Food and Drug Administration has approved Celltrion's Steqeyma (ustekinumab-stba), a biosimilar to Johnson & Johnson's Stelara (ustekinumab), for subcutaneous injection or intravenous infusion in ...
Imuldosa, a Stelara biosimilar, is approved for autoimmune diseases, marking the fifth ustekinumab biosimilar in the US market. Stelara, a top-grossing biologic, underwent CMS price negotiations with ...
BRIDGEWATER, N.J. and BENGALURU, India, Feb. 24, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Changes from induction to week 24 in bowel wall ...
The FDA recently approved STELARA, a prescription medication for adults suffering from Crohn’s disease. Here’s what you need to know: 1. STELARA is manufactured by Janssen Biotech. 2. This treatment ...
RALEIGH, N.C., Aug. 18, 2025 /PRNewswire/ -- Accord BioPharma, Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology ...
Option Care Health’s third quarter results surpassed Wall Street’s revenue and profit expectations, yet the market reacted negatively, reflecting concerns highlighted by management about margin ...
Partners STADA and Alvotech today announced that the European Commission issued a marketing authorization for Uzpruvo® (AVT04), a biosimilar candidate to Stelara® (ustekinumab). The centralized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback